YZFyzfpeptide.comLiraglutide5mgFor Research Use Only
1 / 1
Research product specification
Liraglutide5
Liraglutide
For Research Use Only. Not for human or veterinary use.
Liraglutide is listed for legitimate laboratory and research procurement. This 99%+ research-use product is available in 2 listed specifications. Review product codes, storage guidance and COA status, then request a wholesale quotation. Batch documentation is available on request.
Volume discounts are available for larger purchasing plans. Please contact us for a quotation.
Delivery includedUsually within 7 days after dispatch
Quality resolutionRefund or replacement when approved
24/7 contactWholesale assistance on WhatsApp
Product profile
About Liraglutide
Liraglutide is a synthetic acylated glucagon-like peptide-1 (GLP-1) analogue and a first-generation long-acting GLP-1 receptor agonist. It works by activating GLP-1 receptors to stimulate glucose-dependent insulin secretion, suppress glucagon release, significantly delay gastric emptying, and induce satiety through central nervous system action. As one of the most extensively used GLP-1-based therapies, liraglutide has been approved for both type 2 diabetes management (once daily) and obesity treatment (once daily, higher dose). Its long clinical history and extensive research data provide robust evidence for its safety and efficacy.
Main functions
1.Effective Weight Reduction: Suppresses appetite, enhances satiety, and delays gastric emptying, achieving clinically meaningful weight loss (approximately 5-8% with the 3.0 mg dose).
2.Stable Glycemic Control: Significantly reduces fasting and postprandial blood glucose levels and lowers HbA1c, with a low risk of hypoglycemia.
3.Cardiovascular Benefits: The LEADER trial demonstrated that liraglutide significantly reduces the risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes and high cardiovascular risk, establishing clear cardiovascular protection.
4.Improves Pancreatic Function: Long-term treatment helps preserve pancreatic β-cell function and delays the progression of type 2 diabetes.
5.Comprehensive Metabolic Improvement: Reduces systolic blood pressure, improves lipid profiles, and offers broad optimization of metabolic syndrome-related parameters.
6.Extensive Clinical Experience: Widely used globally since 2009, with substantial real-world data and long-term safety evidence.
Recommended audience
Obese or overweight individuals seeking effective weight loss and metabolic health improvement, especially those intolerant to oral weight-loss medications.
Patients with type 2 diabetes who need combined glycemic control, weight reduction, and cardiovascular benefits.
Patients with established cardiovascular disease or high cardiovascular risk.
Users who prefer a once-daily dosing regimen and have strong confidence in the efficacy and safety of GLP-1-based therapies.
Order formatOne box accepted
QuotationConfirmed on WhatsApp
DeliveryShipping and duties included
DocumentationPublished COA or available on request
Research product specification
Product information
Liraglutide is listed for legitimate laboratory and research procurement. This 99%+ research-use product is available in 2 listed specifications. Review product codes, storage guidance and COA status, then request a wholesale quotation. Batch documentation is available on request.
Handling information
Storage guidance
Keep unopened lyophilized products protected from light and moisture; store at 2-8°C short term or -20°C long term. After reconstitution, refrigerate according to product documentation and minimize freeze-thaw cycles.
Customer-first resolution
Report quality concerns within 14 days of delivery
Contact us with the order number, batch details and available photos. Opened products are accepted for review. When a quality claim is approved, you may choose a full refund or replacement shipment.
